Franco Patrone

Title: Franco Patrone: Innovator in Cancer Treatment

Introduction

Franco Patrone is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of tyrosine kinase inhibitors. With a total of 2 patents, Patrone's work is paving the way for new therapeutic methods in oncology.

Latest Patents

Franco Patrone's latest patents focus on the use of tyrosine kinase inhibitors in conjunction with reduced caloric intake for cancer treatment. One of his patents describes a method where a patient is subjected to a daily caloric intake reduced by 10-100%, including starvation, for a period of 24-190 hours. During this period, a tyrosine kinase inhibitor, preferably selected from Lapatinib, Crizotinib, Gefitinib, Erlotinib, Afatinib, and Regorafenib, is administered to the patient. This innovative approach aims to enhance the efficacy of cancer treatments by combining dietary restrictions with pharmacological interventions.

Career Highlights

Throughout his career, Franco Patrone has worked with esteemed institutions such as the University of Genoa and L-Nutra Inc. His research has focused on developing methods that integrate dietary management with advanced cancer therapies, showcasing his commitment to improving patient outcomes.

Collaborations

Franco Patrone has collaborated with notable colleagues, including Alberto Ballestrero and Irene Caffa. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Franco Patrone's innovative work in the field of cancer treatment exemplifies the potential of combining dietary strategies with pharmacological therapies. His contributions are significant in the ongoing fight against cancer, and his patents reflect a promising direction for future research and treatment methodologies.